News | Colonoscopy Systems | January 31, 2017

Check-Cap Enrolls First Patient in C-Scan Colorectal Cancer Screening Clinical Trial

Trial data will be used to support CE Mark approval of C-Scan ultra-low-dose X-ray screening device

Check-Cap, C-Scan system, colorectal cancer screening, clinical trial, CE Mark

January 31, 2017 — Check-Cap Ltd. recently announced the enrollment of the first patient in its multi-center study of the C-Scan system in support of its CE Mark submission.

C-Scan employs proprietary, ultra-low-dose X-ray technology in an ingestible capsule to create a 3-D map of the inner colon to detect polyps, which may be, or may become, cancerous. Unlike existing imaging modalities, Check-Cap's approach does not require bowel preparation, which is a significant obstacle to screening, according to the company. Designed to improve the patient experience and maximize the number of people who complete screening, C-Scan works in concert with the natural functioning of the colon, and does not require sedation or changes to diet and normal daily activities.

The current multi-center, prospective trial, designed to demonstrate the safety and clinical performance of C-Scan, will evaluate polyp detection as compared to colonoscopy. Check-Cap expects to submit for a CE Mark in the first half of 2017.

The company also plans to initiate a pilot trial in the United States in the second half of 2017, according to Check-Cap CEO Bill Densel.

For more information: www.check-cap.com

Related Content

Sponsored Content | Videos | Digital Radiography (DR) | November 12, 2018
VIVIX-S 1417N is a multi-purpose portable flat panel detector for addressing busy workflow in medical facilities.
ContextVision Introduces AI-Powered Image Enhancement for Digital Radiography
Technology | Artificial Intelligence | November 09, 2018
With the integration of deep learning technology, ContextVision takes digital radiography to new levels with its latest...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more
SBRT Considered Safe Treatment Option for Patients With Multiple Metastases
News | Stereotactic Body Radiation Therapy (SBRT) | November 01, 2018
The NRG Oncology clinical trial BR001 tested the hypothesis that stereotactic body radiotherapy (SBRT) could be used...
Konica Minolta Provides New Insights with AeroRemote Insights
News | Digital Radiography (DR) | November 01, 2018
At the 2018 Radiological Society of North America (RSNA) annual meeting, Nov. 25-30 in Chicago, Konica Minolta...
Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...
Prostate Brachytherapy Shows Low Incidence of Short-Term Complications
News | Brachytherapy Systems | October 31, 2018
A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure-related...